Search Results - "PATOKA, R"

CF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver by Cohen, S., Stemmer, S.M., Zozulya, G., Ochaion, A., Patoka, R., Barer, F., Bar-Yehuda, S., Rath-Wolfson, L., Jacobson, K.A., Fishman, P.

“…The Gi protein‐associated A3 adenosine receptor (A3AR) is a member of the adenosine receptor family. Selective agonists at the A3AR, such as CF101 and CF102…”
Get full text

The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease by Ochaion, A, Bar-Yehuda, S, Cohen, S, Barer, F, Patoka, R, Amital, H, Reitblat, T, Reitblat, A, Ophir, J, Konfino, I, Chowers, Y, Ben-Horin, S, Fishman, P

“…The Gi protein associated A(3) adenosine receptor (A(3)AR) was recently defined as a novel anti-inflammatory target. The aim of this study was to look at…”
Get full text

The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease by Ochaion, A., Bar-Yehuda, S., Cohen, S., Barer, F., Patoka, R., Amital, H., Reitblat, T., Reitblat, A., Ophir, J., Konfino, I., Chowers, Y., Ben-Horin, S., Fishman, P.

Get full text

The As adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats by OCHAION, A, BAR-YEHUDA, S, PEREZ-LIZ, G, FISHMAN, P, COHEN, S, AMITAL, H, JACOBSON, K. A, JOSHI, B. V, GAO, Z. G, BARER, F, PATOKA, R, DEL VALLE, L

Get full text

1411 CF102 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA: A PHASE I/II, OPEN-LABEL, DOSE-ESCALATION STUDY by Stemmer, S.M, Benjaminov, O, Medalia, G, Ciuraru, N.B, Silverman, M.H, Bar-Yehuda, S, Fishman, S, Harpaz, Z, Farbstein, M, Cohen, S, Patoka, R, Singer, B, Kerns, W.D, Fishman, P

Get full text

924 CF102 INDUCES APOPTOSIS OF LIVER CANCER WHILE PREVENTING APOPTOSIS IN LIVER INFLAMMATION: A NEW APPROACH TO TREAT LIVER DISEASES by Cohen, S, Stemmer, S.M, Zozulya, G, Ochaion, A, Patoka, R, Barer, F, Bar Yehuda, S, Rath-Wolfson, L, Fishman, P

Get full text

Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment by Bar‐Yehuda, S., Rath‐Wolfson, L., Del Valle, L., Ochaion, A., Cohen, S., Patoka, R., Zozulya, G., Barer, F., Atar, E., Piña‐Oviedo, S., Perez‐Liz, G., Castel, D., Fishman, P.

“…Objective Studies have suggested that rheumatoid arthritis (RA) and osteoarthritis (OA) share common characteristics. The highly selective A3 adenosine…”
Get full text

The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats by Ochaion, A., Bar-Yehuda, S., Cohen, S., Amital, H., Jacobson, K.A., Joshi, B.V., Gao, Z.G., Barer, F., Patoka, R., Del Valle, L., Perez-Liz, G., Fishman, P.

“…The A 3 adenosine receptor (A 3 AR) is over-expressed in inflammatory cells and was defined as a target to combat inflammation. Synthetic agonists to this…”
Get full text

CF102 an A 3 adenosine receptor agonist mediates anti‐tumor and anti‐inflammatory effects in the liver by Cohen, S., Stemmer, S.M., Zozulya, G., Ochaion, A., Patoka, R., Barer, F., Bar‐Yehuda, S., Rath‐Wolfson, L., Jacobson, K.A., Fishman, P.

“…Abstract The Gi protein‐associated A 3 adenosine receptor (A 3 AR) is a member of the adenosine receptor family. Selective agonists at the A 3 AR, such as…”
Get full text

Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor‐specific antigens by Barnea, Eilon, Beer, Ilan, Patoka, Renana, Ziv, Tamar, Kessler, Ofra, Tzehoval, Esther, Eisenbach, Lea, Zavazava, Nicholas, Admon, Arie

“…The Human MHC Project aims at comprehensive cataloging of peptides presented within the context of different human leukocyte antigens (HLA) expressed by cells…”
Get full text

The A 3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-κB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats by Ochaion, A., Bar-Yehuda, S., Cohen, S., Amital, H., Jacobson, K.A., Joshi, B.V., Gao, Z.G., Barer, F., Patoka, R., Del Valle, L., Perez-Liz, G., Fishman, P.

“…The A 3 adenosine receptor (A 3AR) is over-expressed in inflammatory cells and was defined as a target to combat inflammation. Synthetic agonists to this…”
Get full text

The anti-inflammatory target A sub(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease by Ochaion, A, Bar-Yehuda, S, Cohen, S, Barer, F, Patoka, R, Amital, H, Reitblat, T, Reitblat, A, Ophir, J, Konfino, I, Chowers, Y, Ben-Horin, S, Fishman, P

“…The Gi protein associated A sub(3) adenosine receptor (A sub(3)AR) was recently defined as a novel anti-inflammatory target. The aim of this study was to look…”
Get full text

The anti-inflammatory target A 3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease by Ochaion, A., Bar-Yehuda, S., Cohen, S., Barer, F., Patoka, R., Amital, H., Reitblat, T., Reitblat, A., Ophir, J., Konfino, I., Chowers, Y., Ben-Horin, S., Fishman, P.

“…The Gi protein associated A 3 adenosine receptor (A 3AR) was recently defined as a novel anti-inflammatory target. The aim of this study was to look at A 3AR…”
Get full text

The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats by Ochaion, A, Bar-Yehuda, S, Cohen, S, Amital, H, Jacobson, K A, Joshi, B V, Gao, Z G, Barer, F, Patoka, R, Del Valle, L, Perez-Liz, G, Fishman, P

“…The A(3) adenosine receptor (A(3)AR) is over-expressed in inflammatory cells and was defined as a target to combat inflammation. Synthetic agonists to this…”
Get full text